Marrone Bio Innovations Total Liabilities

Marrone Bio Innovations (MBII) currently reports a total liabilities of $53M as of March 2022. That compares with $51M in the prior-year period — up 4.4% year over year. Use the charts on this page to explore Marrone Bio Innovations's total liabilities history and peer comparisons.

Marrone Bio Innovations's total liabilities increased from $51M to $53M — a 4.4% year-over-year increase (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Marrone Bio Innovations reported $53M in total liabilities as of March 2022. That compares with $51M in the prior-year period — up 4.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $53M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Marrone Bio Innovations, and consider following MBII for alerts when major investors trade the stock.

Marrone Bio Innovations is classified in the Materials sector. On total liabilities, it currently shows $53M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MBII with unrelated industries.